Bris­tol My­ers joins the le­gal fight over in­com­ing Medicare drug price ne­go­ti­a­tions

Bris­tol My­ers Squibb late last week joined Mer­ck and the US Cham­ber of Com­merce in chal­leng­ing the Biden ad­min­is­tra­tion’s sig­na­ture drug pric­ing re­form — al­low­ing, for the first time ever, Medicare to ne­go­ti­ate and rein in drug prices.

In its suit, filed in a New Jer­sey dis­trict court, BMS’ lawyers from Jones Day (the same firm hired by Mer­ck) joined Mer­ck in tak­ing is­sue with the In­fla­tion Re­duc­tion Act’s al­leged vi­o­la­tions of the First and Fifth Amend­ments, writ­ing:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER